Hensin Tsao, MD, PhD, is the Clinical Director of the Mass General Melanoma & Pigmented Lesion Center, Director of the Melanoma Genetics Program, and a member of the Massachusetts General Hospital Cancer Center's Center for Melanoma.
- Centers & Specialties
- Clinical Interests
- Genetic skin disorders
- Skin cancer
- Medical Education
- PhD, Columbia University
- MD, Columbia University College of Physicians and Surgeons
- Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Foreign Languages
- Boston: Massachusetts General Hospital
- Patient Gateway
- Yes, learn more
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
Hensin Tsao, MD, PhD is a board-certified dermatologist and Professor of Dermatology at Harvard Medical School. Presently, he is Director of the Melanoma and Pigmented Lesion Center, the Melanoma Genetics Program, and the Skin Cancer Genetics Laboratory in the Wellman Center for Photomedicine, all of which are at the Massachusetts General Hospital. Beyond patient care, he dedicates much of his time to melanoma research and the education of medical students, dermatology residents, and fellows.
Hensin Tsao, MD, PhD received his undergraduate degree from Brown University where he graduated magna cum laude and Phi Beta Kappa. Later, he graduated Alpha Omega Alpha from the Columbia University College of Physicians and Surgeons with a MD degree and received his PhD from Columbia University Graduate School of Arts of Sciences. Dr. Tsao completed one year of clinical training in internal medicine and three years of dermatology residency, including one-year Melanoma Fellowship in the Harvard-affliated hospitals. He concluded his training with a postdoctoral fellowship in the Division of Oncology at Massachusetts General Hospital.
Dr. Tsao supervises an active cancer genetics laboratory and is the author of more than 100 scholarly articles, reiews, abstracts, textbook chapters, and online media texts. He has also delivered more than 100 lectures on melanoma, genetics, and skin disease throughout the world. To learn more visit The Wellman Center for Photomedicine.
Browse the latest local and national news articles featuring stories from basic research to innovative breakthroughs in cosmetic dermatology.
A major international study has identified a novel gene mutation that appears to increase the risk of both inherited and sporadic cases of malignant melanoma, the most deadly form of skin cancer. The identified mutation occurs in the gene encoding MITF, a transcription factor that induces the production of several important proteins in melanocytes, the cells in which melanoma originates.
Hensin Tsao, MD, recommends what you can do to protect your family from melanoma
Hensin Tsao, MD, Director of Mass General's Melanoma and Pigmented Lesion Center explains how family history, genetic risks and personal health history can all affect your risk of melanoma, and what steps you should take to detect it at an early, treatable stage.
50 Staniford Street
Boston, MA 02114-2517